Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

Herbal treatments are gaining interest as alternatives for hair loss.

SFRP2 and PTGDS may be key factors in female hair loss.

Innate lymphoid cells help us understand and manage allergic diseases better.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

More research is needed to find effective treatments for sickle cell disease-related priapism.

ATP helps prevent skin damage from vandetanib by reducing stress.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.